Search Results - "Boyd, Timothy D."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Treatment with Granulocyte-Macrophage Colony-Stimulating Factor Reduces Viral Titers in the Brains of West Nile Virus-Infected Mice and Improves Survival by Stonedahl, Sarah, Leser, J Smith, Clarke, Penny, Potter, Huntington, Boyd, Timothy D, Tyler, Kenneth L

    Published in Journal of virology (30-03-2023)
    “…West Nile virus (WNV) is the leading cause of epidemic arboviral encephalitis in the United States. As there are currently no proven antiviral therapies or…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners? by Ahmed, Md Mahiuddin, Johnson, Noah R, Boyd, Timothy D, Coughlan, Christina, Chial, Heidi J, Potter, Huntington

    Published in Frontiers in aging neuroscience (16-09-2021)
    “…Innate immune system activation and inflammation are associated with and may contribute to clinical outcomes in people with Down syndrome (DS),…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19 [version 1; peer review: 1 approved, 2 approved with reservations] by Potter, Huntington, Boyd, Timothy D, Clarke, Penny, Pelak, Victoria S, Tyler, Kenneth L

    Published in F1000 research (2020)
    “…As the coronavirus disease 2019 (COVID-19) pandemic grows throughout the world, it is imperative that all approaches to ameliorating its effects be…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Granulocyte‐macrophage colony‐stimulating factor reverses Alzheimer’s disease pathology in the tgf344‐AD rat model by Ahmed, Md. Mahiuddin, Wang, Athena Ching‐Jung, Boyd, Timothy D., Solano, D. Adriana, Vielle, Anne, Markham, Neil, Coughlan, Christina M, Chial, Heidi J, Vergara, M. Natalia, Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), a hematopoietic growth factor, has shown therapeutic and neuroprotective effects in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    GM‐CSF reduces amylin amyloid, inhibits pancreatic apoptosis, and sustains lowered blood glucose levels in the hIAPP mouse model of Type 2 diabetes mellitus, a known risk factor for Alzheimer’s disease by Wang, Athena Ching‐Jung, Boyd, Timothy D., Adame, Vanesa, Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background People with Type II diabetes mellitus (T2D) are at higher risk for developing Alzheimer’s disease (AD). T2D is characterized histopathologically by…”
    Get full text
    Journal Article
  11. 11

    GM‐CSF reduces amylin amyloid and prevents pancreatic cell death in the hIAPP mouse model of Type 2 diabetes mellitus, a known risk factor for Alzheimer’s disease by Wang, Athena Ching‐Jung, Boyd, Timothy D., Markham, Neil, Adame, Vanesa, Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background People with Type II diabetes mellitus (T2D) are at higher risk for developing Alzheimer’s disease (AD). T2D is characterized histopathologically by…”
    Get full text
    Journal Article
  12. 12

    GM‐CSF Treatment Increases the Number of Purkinje Cells in a Mouse Model of Down Syndrome by Ahmed, Md. Mahiuddin, Aghili, Leila, Wang, Athena Ching‐Jung, Elos, Mihret, Boyd, Timothy D., Chial, Heidi J, Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Down syndrome (DS), the most common chromosomal disorder that is a genetic cause of intellectual disability (ID), is characterized by mild‐to‐severe…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The Potential Alzheimer’s Disease Drug, GM‐CSF, Enhances the Anti‐Viral Immune Response and Reduces Mortality in a Mouse Model of COVID‐19 by Kendall, Lon V., Boyd, Timothy D., Sillau, Stefan H, Bosco‐Lauth, Angela, Markham, Neil, Fong, Derek, Clarke, Penny, Tyler, Kenneth L., Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background COVID‐19 results in increased expression of inflammatory cytokines and Alzheimer’s disease (AD) biomarkers of neuronal damage, but…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Inflammation and innate immune system activation in neurodegeneration, Down syndrome, aging, and infection: Therapeutic target or partner? by Potter, Huntington, Boyd, Timothy D., Ahmed, Md. Mahiuddin, Kendall, Lon V., Sillau, Stefan H, Coughlan, Christina M, Clarke, Penny, Stonedahl, Sarah, Chial, Heidi J

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Characteristic features/biomarkers of innate immune system activation and inflammation are associated with neurodegenerative diseases (e.g.,…”
    Get full text
    Journal Article
  17. 17

    Traumatic Brain Injury Exacerbates Retinal Alzheimer’s Disease Histopathology in the TgF344 Rat Model by Vergara, M. Natalia, Secora, Conner N, Vielle, Anne, Wang, Athena Ching‐Jung, Lenhart, Patricia, Salcedo, Ernesto, Johnson, Noah R, Ahmed, Md. Mahiuddin, Chial, Heidi J, Boyd, Timothy D., Potter, Huntington

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Alzheimer’s disease (AD) is a neurodegenerative condition of the central nervous system that affects both the brain and the retina, and can lead to…”
    Get full text
    Journal Article
  18. 18
  19. 19